| Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience. F Diurno, FG Numis, G Porta, F Cirillo, S Maddaluno, A Ragozzino, ... European Review for Medical & Pharmacological Sciences 24 (7), 2020 | 393 | 2020 |
| Endoscopic management of foreign bodies in the upper gastrointestinal tract: report on a series of 414 adult patients S Mosca, G Manes, R Martino, L Amitrano, V Bottino, A Bove, A Camera, ... Endoscopy 33 (08), 692-696, 2001 | 313 | 2001 |
| Peginterferon alfa-2a plus ribavirin is more effective than peginterferon alfa-2b plus ribavirin for treating chronic hepatitis C virus infection A Ascione, M De Luca, MT Tartaglione, F Lampasi, GG Di Costanzo, ... Gastroenterology 138 (1), 116-122, 2010 | 268 | 2010 |
| Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation FP Picciotto, G Tritto, AG Lanza, L Addario, M De Luca, GG Di Costanzo, ... Journal of Hepatology 46 (3), 459-465, 2007 | 217 | 2007 |
| Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B P Lampertico, M Viganò, GG Di Costanzo, E Sagnelli, M Fasano, ... Gut 62 (2), 290-298, 2013 | 155 | 2013 |
| Natural history of chronic hepatitis C virus infection A Ascione, MT Tartaglione, GG Di Costanzo Digestive and Liver Disease 39, S4-S7, 2007 | 110 | 2007 |
| Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: A randomized trial GG Di Costanzo, R Tortora, G D'Adamo, M De Luca, F Lampasi, L Addario, ... Journal of gastroenterology and hepatology 30 (3), 559-565, 2015 | 95 | 2015 |
| Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study CKY Ng, GG Di Costanzo, N Tosti, V Paradiso, M Coto-Llerena, ... Annals of Oncology 29 (5), 1286-1291, 2018 | 91 | 2018 |
| Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis M Rimini, L Rimassa, K Ueshima, V Burgio, S Shigeo, T Tada, G Suda, ... ESMO open 7 (6), 100591, 2022 | 83 | 2022 |
| Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives GG Di Costanzo, G Francica, CM Pacella World journal of hepatology 6 (10), 704, 2014 | 80 | 2014 |
| Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation F Trevisani, G Brandi, F Garuti, MA Barbera, R Tortora, A Casadei Gardini, ... Journal of Cancer Research and Clinical Oncology 144, 403-414, 2018 | 58 | 2018 |
| Assessing the impact of COVID-19 on liver cancer management (CERO-19) S Muñoz-Martínez, V Sapena, A Forner, JC Nault, G Sapisochin, ... JHEP reports 3 (3), 100260, 2021 | 52 | 2021 |
| Circulating cell-free DNA in hepatocellular carcinoma: current insights and outlook CKY Ng, GG Di Costanzo, LM Terracciano, S Piscuoglio Frontiers in medicine 5, 78, 2018 | 50 | 2018 |
| A novel needle guide system to perform percutaneous laser ablation of liver tumors using the multifiber technique GG Di Costanzo, G D'Adamo, R Tortora, F Zanfardino, S Mattera, ... Acta Radiologica 54 (8), 876-881, 2013 | 45 | 2013 |
| Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey D Santini, F Pantano, F Riccardi, GG Di Costanzo, R Addeo, FM Guida, ... PLoS One 9 (8), e105268, 2014 | 44 | 2014 |
| Real‐life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study M Persico, A Aglitti, M Milella, C Coppola, V Messina, E Claar, I Gentile, ... Liver International 39 (10), 1852-1859, 2019 | 41 | 2019 |
| Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis M Guarino, L Viganò, FR Ponziani, EG Giannini, Q Lai, F Morisco, A Vitale, ... Digestive and Liver Disease 50 (11), 1105-1114, 2018 | 39 | 2018 |
| Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study L Addario, G Scaglione, G Tritto, GG Di Costanzo, M De Luca, F Lampasi, ... European journal of gastroenterology & hepatology 18 (7), 713-720, 2006 | 38 | 2006 |
| Sorafenib off-target effects predict outcomes in patients treated for hepatocellular carcinoma GG Di Costanzo, G de Stefano, R Tortora, N Farella, L Addario, F Lampasi, ... Future Oncology 11 (6), 943-951, 2015 | 37 | 2015 |
| Impact of age on toxicity and efficacy of sorafenib-targeted therapy in cirrhotic patients with hepatocellular carcinoma GG Di Costanzo, R Tortora, M De Luca, A Galeota Lanza, F Lampasi, ... Medical Oncology 30, 1-8, 2013 | 37 | 2013 |
